R

Ralf J.P. van der Valk

Alexion Pharmaceuticals (United States)

ORCID: 0000-0002-3052-2796

34 papers and 1.8k citations.

PubIndex Score96Top 4% · mid-careerHow it's scored

34Publications

1.8kTotal Citations

First senior author: 2019

Top publicationsby citations

Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America

Jennifer K Quint, Yvette M. Weesie, Chantal Touboul et al.|The Journal of Allergy and Clinical Immunology In Practice|2022

Cited by 79

Indexing the rest of 34 publications…